Healthcare Triangle Stock Price To Sales
| HCTI Stock | USD 1.09 0.02 1.87% |
Healthcare Triangle fundamentals help investors to digest information that contributes to Healthcare Triangle's financial success or failures. It also enables traders to predict the movement of Healthcare Stock. The fundamental analysis module provides a way to measure Healthcare Triangle's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Healthcare Triangle stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 0.35 | 0.33 |
Healthcare | Price To Sales |
Healthcare Triangle Company Price To Sales Analysis
Healthcare Triangle's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Healthcare Triangle Price To Sales | 0.28 X |
Most of Healthcare Triangle's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healthcare Triangle is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Healthcare Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Healthcare Triangle is extremely important. It helps to project a fair market value of Healthcare Stock properly, considering its historical fundamentals such as Price To Sales. Since Healthcare Triangle's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Healthcare Triangle's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Healthcare Triangle's interrelated accounts and indicators.
Click cells to compare fundamentals
Healthcare Price To Sales Historical Pattern
Today, most investors in Healthcare Triangle Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Healthcare Triangle's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Healthcare Triangle price to sales as a starting point in their analysis.
Healthcare Triangle Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Healthcare Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Healthcare Triangle has a Price To Sales of 0.2816 times. This is 98.68% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 97.53% higher than that of the company.
Healthcare Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healthcare Triangle's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Healthcare Triangle could also be used in its relative valuation, which is a method of valuing Healthcare Triangle by comparing valuation metrics of similar companies.Healthcare Triangle is currently under evaluation in price to sales category among its peers.
Healthcare Fundamentals
| Return On Equity | -2.88 | ||||
| Return On Asset | -0.55 | ||||
| Profit Margin | (0.49) % | ||||
| Operating Margin | (0.46) % | ||||
| Current Valuation | 7.23 M | ||||
| Shares Outstanding | 5.67 M | ||||
| Shares Owned By Insiders | 45.93 % | ||||
| Shares Owned By Institutions | 3.27 % | ||||
| Number Of Shares Shorted | 632.84 K | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 0.28 X | ||||
| Revenue | 33.2 M | ||||
| Gross Profit | 10.52 M | ||||
| EBITDA | (4.1 M) | ||||
| Net Income | (12.34 M) | ||||
| Cash And Equivalents | 1.36 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 4.32 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 1.42 X | ||||
| Book Value Per Share | 0.12 X | ||||
| Cash Flow From Operations | (1.61 M) | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | (2.17) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 22 | ||||
| Beta | 0.49 | ||||
| Market Capitalization | 6.18 M | ||||
| Total Asset | 10.05 M | ||||
| Retained Earnings | (24.91 M) | ||||
| Working Capital | (2.39 M) | ||||
| Current Asset | 30 K | ||||
| Current Liabilities | 10.13 M | ||||
| Net Asset | 10.05 M |
About Healthcare Triangle Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Healthcare Triangle's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healthcare Triangle using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healthcare Triangle based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Healthcare Triangle offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthcare Triangle's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthcare Triangle Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthcare Triangle Stock:Check out Healthcare Triangle Piotroski F Score and Healthcare Triangle Altman Z Score analysis. For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Triangle. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Triangle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share 4.813 | Quarterly Revenue Growth (0.65) | Return On Assets (0.55) | Return On Equity (2.88) |
The market value of Healthcare Triangle is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Triangle's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Triangle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Triangle's market value can be influenced by many factors that don't directly affect Healthcare Triangle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Triangle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Triangle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Triangle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.